PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer.

about

Comparative study of ultrasonic elastography and conventional ultrasound in diagnosis of malignant anus neoplasm.

P2860

Q49884464-A6D85EDE-5914-4DC5-AB48-19CC4F09D566

P2860

PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer.

Item

http://www.wikidata.org/entity/Q47748562

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

PET-CT guided SIB-IMRT combine ...... the treatment of anal cancer.

@en

PET-CT guided SIB-IMRT combine ...... the treatment of anal cancer.

@nl

type

Item

label

PET-CT guided SIB-IMRT combine ...... the treatment of anal cancer.

@en

PET-CT guided SIB-IMRT combine ...... the treatment of anal cancer.

@nl

prefLabel

PET-CT guided SIB-IMRT combine ...... the treatment of anal cancer.

@en

PET-CT guided SIB-IMRT combine ...... the treatment of anal cancer.

@nl

P1476

PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer

@en

P2093

Christoph Oehler

http://www.w3.org/2001/XMLSchema#string

Daniel R Zwahlen

http://www.w3.org/2001/XMLSchema#string

Jürgen Beer

http://www.w3.org/2001/XMLSchema#string

Michel Zimmermann

http://www.w3.org/2001/XMLSchema#string

Roger von Moos

http://www.w3.org/2001/XMLSchema#string

Vasiliki Vlachopoulou

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2016

Cancer statistics, 2006

US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.

Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.

One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity.

FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53

The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.

Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.

P304

1734-1740

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1325003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephan Bodis

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28557585

http://www.w3.org/2001/XMLSchema#string

PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer.

about

P2860

P2860

PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698